[Antimediatory therapy in the complex treatment of acute destructive pancreatitis].
Gorskiĭ
V A
VA
Koval'chuk
L V
LV
Agapov
M A
MA
Khoreva
M V
MV
Ovanesian
E R
ER
Nikonova
A S
AS
Grechenko
V V
VV
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D016207:Cytokines / Q000037:antagonists & inhibitors* / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D019283:Pancreatitis, Acute Necrotizing / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D010894:Piroxicam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies; D051193:Toll-Like Receptors / Q000037:antagonists & inhibitors* / Q000097:blood; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016207:Cytokines; D051193:Toll-Like Receptors; D010894:Piroxicam; C059451:lornoxicam